Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000769993-25-000240
Filing Date
2025-05-09
Accepted
2025-05-09 12:28:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9697
2 POA13G-1500100555_20250402.txt EX-99 5141
  Complete submission text file 0000769993-25-000240.txt   16938
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

EIN.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 333 LUDLOW STREET NORTH TOWER, 6TH FLOOR STAMFORD CT 06902
Business Address 333 LUDLOW STREET NORTH TOWER, 6TH FLOOR STAMFORD CT 06902 888-729-1206
GeneDx Holdings Corp. (Subject) CIK: 0001818331 (see all company filings)

EIN.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91664 | Film No.: 25929235
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)